Document Type : Original Article

Authors

1 Kavosh Cognitive Behavior Sciences and Addiction Research Center, Department of Psychiatry, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

2 Otorhinolaryngology Research Center, Department of Otolaryngology and Head and Neck Surgery, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

3 Department of Mental Health, Vice-chancellor of health, Guilan University of Medical Science, Rasht, Iran

Abstract

Background: The literature indicates a link between schizophrenia and a disturbance in innate and adaptive immunity. However, the results about allergic rhinitis have been inconsistent so far. The aim of this population-based study was to investigate the prevalence and clinical features of allergic rhinitis in patients with schizophrenia.
Methods: This cross-sectional study was performed on 998 patients and 1000 age- and sex-matched control subjects from March 2013 to August 2014. All participants were assessed by the Score for Allergic Rhinitis (SFAR) questionnaire and nasal smear (for eosinophilia) investigation. Symptoms were assessed using the Brief Psychiatric Rating Scale (BPRS). Univariable and multivariable logistic regression models were fitted to estimate adjusted odds ratios.
Results: The mean age of subjects was 45.0 years, and 61.0% of subjects of either group were male. About 26.5% of subjects in the case group and 21.0% in the control group had allergic rhinitis. The patients with schizophrenia were found to be at an increased risk for allergic rhinitis (adjusted OR 1.41, 95% CI 1.08-1.83) compared to control subjects. Furthermore, multivariable logistic regression identified the affect subscale on the BPRS as a risk factor of allergic rhinitis (P=0.004).
Conclusion: Our results suggest that the prevalence of allergic rhinitis is higher in patients with schizophrenia. However, the impact of type and severity of allergic rhinitis on the course of schizophrenia must be investigated in further trials.

Keywords

  1. Freedman R. Schizophrenia. N Engl J Med 2003; 349(18):1738-49. doi: 10.1056/nejmra035458.
  2. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013; 10:43. doi: 10.1186/1742-2094-10-43.
  3. Chen SJ, Chao YL, Chen CY, Chang CM, Wu EC, Wu CS, et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry 2012; 200(5):374-80. doi: 10.1192/bjp.bp.111.092098.
  4. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006; 163(3):521-28. doi: 10.1176/appi.ajp.163.3.521.
  5. Khandaker GM, Cousins L, Deakin J, Lennox BR, Yolken R, Jones PB. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2015; 2(3):258-70. doi: 10.1016/s2215-0366(14)00122-9.
  6. Chen YH, Lee HC, Lin HC. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res 2009; 108(1-3):191-6. doi: 10.1016/j.schres.2008.12.021.
  7. Okusaga O, Hamilton RG, Can A, Igbide A, Giegling I, Hartmann AM, et al. Phadiatop seropositivity in schizophrenia patients and controls: a preliminary study. AIMS Public Health 2014; 1(2):43-50. doi: 10.3934/publichealth.2014.2.43.
  8. Wang WC, Lu ML, Chen VC, Ng MH, Huang KY, Hsieh MH, et al. Asthma, corticosteroid use and schizophrenia: A nationwide population-based study in Taiwan. PloS One 2017; 12(3):e0173063. doi: 10.1371/journal.pone.0173063.
  9. First MB, Spitzer RL, Gibbon ML, Williams JB. Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. New York: New York State Psychiatric Institute; 2002.
  10. Shafer A. Meta-analysis of the brief psychiatric rating scale factor structure. Psychol Assess 2005; 17(3):324-35. doi: 1037/1040-3590.17.3.324.
  11. Ologe FE, Adebola SO, Dunmade AD, Adeniji KA, Oyejola BA. Symptom score for allergic rhinitis. Otolaryngol Head Neck Surg 2013; 148(4):557-63. doi: 10.1177/0194599813477605.
  12. Annesi-Maesano I, Dider I, Klossek M, Chanel L, Morean D, Bousquet J. The Score for Allergic Rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy 2002; 57(2):107-14. doi: 10.1034/j.1398-9995.2002.1o3170.x.
  13. Sood Diagnostic significance of nasal eosinophilia in allergic rhinitis. Indian J Otolaryngol Head Neck Surg 2005; 57(1):13-6. doi: 10.1007/BF02907618.
  14. Varasteh AR, Fereidouni M, Shakeri MT,Vahedi F, Abolhasani A, Saberi Afsharian M, et al. Prevalence of allergic disorders among the population in the city of Mashhad, Northeast Iran. J Public Health 2009; 17(2):107-12. doi: 10.1007/s10389-008-0217-6.
  15. Fazlollahi MR, Souzanchi G, Nourizadeh M, Sabetkish N, Tazesh B, Entezari A, et al. The prevalence of allergic rhinitis and it's relationship with second-hand tobacco smoke among adults in Iran. Acta Med Iran 2017; 55(11): 712-7.
  16. Saulyte J, Regueira C, Montes-Martinez A, Khudyakov P, Takkouche B. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med 2014; 11(3):e1001611. doi: 10.1371/journal.pmed.1001611.
  17. An SY, Choi HG, Kim SW, Park B, Lee JS, Jang JH, et Analysis of various risk factors predisposing subjects to allergic rhinitis. Asian Pac J Allergy Immunol 2015; 33(2):143-51. doi: 10.12932/AP0554.33.2.2015.
  18. Pasaoglu G, Bavbek S, Tugcu H, Abadoglu O, Misirligil Z. Psychological status of patients with chronic urticaria. J Dermatol 2006; 33(11):765-71. doi: 10.1111/j.1346-8138.2006.00178.x.
  19. Lv X, Han D, Xi L, Zhang L. Psychological aspects of female patients with moderate-to-severe persistent allergic rhinitis. ORL J Otorhinolaryngol Relat Spec 2010; 72(5):235-41. doi: 10.1159/000314884.
  20. Begemann MJ, Linszen MM, de Boer JN, Hovenga WD, Gangadin SS, Schutte MJ, et al. Atopy increases risk of psychotic experiences: a large population-based study. Front Psychiatry 2019; 10:453. doi: 10.3389/fpsyt.2019.00453.
  21. Chiang SS, Riedel M, Schwarz M, Mueller N. Is T-helper type 2 shift schizophrenia-specific? Primary results from a comparison of related psychiatric disorders and healthy controls. Psychiatry Clin Neurosci 2013; 67(4):228-36. doi: 10.1111/pcn.12040.
  22. Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2014; 48:277-86. doi: 10.1016/j.pnpbp.2012.10.022.
  23. Turgan A, Ural A, Işık AU, Arslan S, Capkin E, Sari RA. A preliminary report on the prevalence and clinical features of allergic rhinitis in ankylosing spondylitis patients. ENT Updates 2015; 5(1):35-40. doi: 10.2399/jmu.2015001009.
  24. Sanz ML, Prieto I, Garcia BE, Oehling A. Diagnostic reliability considerations of specific IgE determination. J Investig Allergol Clin Immunol 1996; 6(3):152-61.